17
Fitzgerald Health Education Associates, Inc., December 2014 fhea.com
Gardasil 9 Approved for
Prevention of Cancers
Caused by 5 Additional
HPV Types
The FDA approved Gardasil 9
(Human Papillomavirus 9-valent Vaccine, recombi-
nant) for the prevention of certain diseases caused
by nine types of human papillomavirus (HPV ). Cover-
ing nine HPV types, five more HPV types than the
previously approved Gardasil vaccine, Gardasil 9 has
the potential to prevent approximately 90% of cervi-
cal, vulvar, vaginal, and anal cancers, according to
the FDA. Gardasil 9 is a product of Merck.
The new vaccine is approved for use in females
ages 9 through 26 and males ages 9 through 15. It is
approved for prevention of cervical, vulvar, vaginal,
and anal cancers caused by HPV types 16, 18, 31, 33,
45, 52, and 58, and for the prevention of genital
warts caused by HPV types 6 or 11. Gardasil 9 adds
protection from five additional types of HPV (31, 33,
45, 52, and 58) that cause approximately 20% of cer-
vical cancers and are not covered by previously ap-
proved HPV vaccines.
Gardasil 9 is administered as three separate shots,
with the initial dose followed by additional shots
given 2 and 6 months later. Maximum benefit from
Gardasil 9 vaccination is realized by those who are
vaccinated prior to becoming infected with the HPV
strains covered by the vaccine.
Click here for more information.
Use of Bedding for Infant Sleep Still
Common Despite Warnings
The use of bedding for sleeping infants remains com-
mon despite recommendations against this practice
News Briefs
Did your certification lapse?
Do you practice in a state
that didn't require you to
become certified?
Fitzgerald Health can help you
prepare for your certification exam!
•
Certification exams are tailored to new NPs, so
they can be challenging for practicing NPs
•
Fitzgerald Health Certification Review provides
strategies to help you prepare for the exam!
Learn more from our FREE
75-minute presentation
Getting Ready for the
NP Certification Exam
Register for the March 3, 2015,
Webinar at 8 PM EDT, or view
Online On Demand
Fitzgerald Health Education Associates, Inc.
Trying to keep up with guideline
changes for hypertension and
dyslipidemia? Get the latest clinical
updates from a trusted educator,
Dr. Margaret A. Fitzgerald
Hypertension Update
Online • CD
Dyslipidemia:
An Update on Treatment
Goals and Options
Online • CD
Fitzgerald Health Education Associates, Inc.